comparemela.com

Latest Breaking News On - Eyepoint pharmaceuticals trading down - Page 1 : comparemela.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Sees Unusually-High Trading Volume

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) saw an uptick in trading volume on Tuesday . 604,426 shares traded hands during mid-day trading, a decline of 40% from the previous session’s volume of 1,005,304 shares.The stock last traded at $27.86 and had previously closed at $26.55. Analyst Upgrades and Downgrades A number of brokerages […]

United-states
American
Darioa-paggiarino
Jpmorgan-chase-co
Eyepoint-pharmaceuticals-trading-down
Eyepoint-pharmaceuticals-inc
American-international-group-inc
Mirae-asset-global-investments-co
Tower-research-capital
Deutsche-bank
Investment-advisers

Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Price Target at $33.00

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five ratings firms that are presently covering the stock, MarketBeat reports. Five research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in […]

Schonfeld-strategic-advisors
Insider-transactions-at-eyepoint-pharmaceuticals
Lazard-asset-management
Nasdaq
Eyepoint-pharmaceuticals-inc
Eyepoint-pharmaceuticals-company-profile
Eyepoint-pharmaceuticals-trading-down
Cubist-systematic-strategies
Analyst-recommendations-for-eyepoint-pharmaceuticals
Barclays-plc
News-ratings-for-eyepoint-pharmaceuticals-daily

EyePoint Pharmaceuticals (NASDAQ:EYPT) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) in a research report sent to investors on Saturday. The brokerage issued a hold rating on the stock. Other research analysts also recently issued reports about the company. Chardan Capital restated a buy rating and issued a $22.00 price target on shares of […]

China
United-states
United-kingdom
Eyepoint-pharmaceuticals
Barclays-plc
Eyepoint-pharmaceuticals-trading-down
Eyepoint-pharmaceuticals-inc
Schonfeld-strategic-advisors
Tower-research-capital
Eyepoint-pharmaceuticals-company-profile
Cubist-systematic-strategies

EyePoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 5.1%

EyePoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 5.1%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Blackrock
United-kingdom-general
United-kingdom
United-states
China
Nasdaq
Eyepoint-pharmaceuticals-inc
Blackrock-inc
Suvretta-capital-management
Eyepoint-pharmaceuticals
Vanguard-group-inc

vimarsana © 2020. All Rights Reserved.